# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000078003-19-000015
Filing Date
2019-02-28
Accepted
2019-02-28 14:35:32
Documents
229
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | pfe-12312018x10kshell.htm | 10-K | 882268
2 | STOCK AND ASSET PURCHASE AGREEMENT | pfe-exhibit22x12312018x10k.htm | EX-2.2 | 1516535
3 | AMENDMENT NO 1 PFIZER CONSOLIDATED SUPP PENSION PLAN FOR US & PR EMPLYS | pfe-exhibit107x12312018x10k.htm | EX-10.7 | 52175
4 | AMENDMENT NO 4 TO THE PFIZER SUPPLEMENTAL SAVINGS PLAN | pfe-exhibit1012x12312018x1.htm | EX-10.12 | 4492
5 | AMENDMENT NO 5 TO THE PFIZER SUPPLEMENTAL SAVINGS PLAN | pfe-exhibit1013x12312018x1.htm | EX-10.13 | 4931
6 | AMENDMENT NO 1 PFIZER INC EXECUTIVE SEVERANCE PLAN | pfe-exhibit1026x12312018x1.htm | EX-10.26 | 37092
7 | TIME SHARING AGREEMENT | pfe-exhibit1033x12312018x1.htm | EX-10.33 | 35684
8 | 2018 FINANCIAL REPORT | pfe-exhibit13x12312018x10k.htm | EX-13 | 7393145
9 | SUBSIDIARIES OF THE COMPANY | pfe-exhibit21x12312018x10k.htm | EX-21 | 233758
10 | CONSENT OF KPMG, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | pfe-exhibit23x12312018x10k.htm | EX-23 | 9435
11 | CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER - 302 | pfe-exhibit311x12312018x10k.htm | EX-31.1 | 9723
12 | CERTIFICATION BY THE CHIEF FINANCIAL OFFICER - 302 | pfe-exhibit312x12312018x10k.htm | EX-31.2 | 9864
13 | CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER - 906 | pfe-exhibit321x12312018x10k.htm | EX-32.1 | 6572
14 | CERTIFICATION BY THE CHIEF FINANCIAL OFFICER - 906 | pfe-exhibit322x12312018x10k.htm | EX-32.2 | 6622
21 |  | adjdilutedepsnon-gaap2018.jpg | GRAPHIC | 9670
22 |  | albertbourlasignatureq42018.jpg | GRAPHIC | 1950
23 |  | compofincreaseiniehrev2017.jpg | GRAPHIC | 27623
24 |  | compofincreaseiniehrev2018.jpg | GRAPHIC | 27190
25 |  | compofincreaseinihrev2017.jpg | GRAPHIC | 23034
26 |  | compofincreaseinihrev2018.jpg | GRAPHIC | 23300
27 |  | countriesoutsideus500revenue.jpg | GRAPHIC | 19656
28 |  | franksignatureq42018.jpg | GRAPHIC | 15323
29 |  | globe.jpg | GRAPHIC | 5921
30 |  | kpmgsignatureq42018.jpg | GRAPHIC | 2159
31 |  | lorettasignatureq42018.jpg | GRAPHIC | 19069
32 |  | marketgrowth.jpg | GRAPHIC | 4040
33 |  | microscope.jpg | GRAPHIC | 4196
34 |  | netcashflow-operations2018.jpg | GRAPHIC | 9736
35 |  | numbercountoutsideus500mil.jpg | GRAPHIC | 17052
36 |  | overviewrev2018v2017.jpg | GRAPHIC | 27412
37 |  | peergroupgraph.jpg | GRAPHIC | 52112
38 |  | pehlogo.jpg | GRAPHIC | 39805
39 |  | pfizercoverlogoa01.jpg | GRAPHIC | 95651
40 |  | pfizerlogo.jpg | GRAPHIC | 26092
41 |  | pfizerlogowithtagline.jpg | GRAPHIC | 16639
42 |  | pfizerpipeline012919.jpg | GRAPHIC | 102416
43 |  | pharmapack.jpg | GRAPHIC | 5051
44 |  | pharmapill.jpg | GRAPHIC | 3843
45 |  | pihlogo.jpg | GRAPHIC | 42641
46 |  | prescription.jpg | GRAPHIC | 4529
47 |  | reporteddilutedeps2018.jpg | GRAPHIC | 8239
48 |  | revbysegmentandgeography.jpg | GRAPHIC | 51086
49 |  | revenuesbycustomer.jpg | GRAPHIC | 17555
50 |  | revenuesbynationalmarket.jpg | GRAPHIC | 47342
51 |  | revsbynationalmarket.jpg | GRAPHIC | 37656
52 |  | structure.jpg | GRAPHIC | 4173
53 |  | syringe.jpg | GRAPHIC | 3924
54 |  | team.jpg | GRAPHIC | 5115
55 |  | testtubes.jpg | GRAPHIC | 4931
56 |  | totalrevenue2018.jpg | GRAPHIC | 10125
57 |  | usrevenuesbycustomer.jpg | GRAPHIC | 18711
| Complete submission text file | 0000078003-19-000015.txt |  | 46846663

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL INSTANCE DOCUMENT | pfe-20181231.xml | EX-101.INS | 13010438
16 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | pfe-20181231.xsd | EX-101.SCH | 218320
17 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | pfe-20181231_cal.xml | EX-101.CAL | 283152
18 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | pfe-20181231_def.xml | EX-101.DEF | 1530410
19 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | pfe-20181231_lab.xml | EX-101.LAB | 2401042
20 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | pfe-20181231_pre.xml | EX-101.PRE | 1842861

Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-03619 | Film No.: 19642404
SIC: 2834 Pharmaceutical Preparations